<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00501982</url>
  </required_header>
  <id_info>
    <org_study_id>DM/PR/5000/002/04</org_study_id>
    <nct_id>NCT00501982</nct_id>
  </id_info>
  <brief_title>Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study</brief_title>
  <acronym>Curpap</acronym>
  <official_title>An International, Open, Randomized, Controlled Study to Evaluate the Efficacy of Combining Prophylactic Curosurf® With Early Nasal CPAP Versus Early Nasal CPAP Alone in Very Preterm Infants at Risk of Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare two methods of post-delivery stabilization
      and subsequent early respiratory care for reducing the need for MV and related secondary
      complications, such as BPD, in premature babies at high risk of RDS:

        1. Early stabilization on nCPAP

        2. Intubation, prophylactic surfactant (Curosurf®) administration shortly after delivery,
           and rapid extubation to nCPAP.

      The data obtained from this comparison will be applied to test the hypothesis that preterm
      neonates at risk of RDS who are treated with prophylactic surfactant + nCPAP show less need
      for MV when compared to infants who receive nCPAP alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Need for MV</measure>
    <time_frame>Within the first 5 days of life</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of BPD and other complications of prematurity. Lenght of hospitalization. Clinical status until discharge home</measure>
    <time_frame>entire study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">208</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>N Cpap in delivery room and than rescue curosurf in case of need</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Poractant alfa (Curosurf) + N Cpap in delivery room</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Poractant alfa (Curosurf®)</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm neonates with a gestational age (GA) of 25+0 - 28+6 completed weeks.

          -  Inborn neonates.

          -  In case of twins, both neonates will be included in the same treatment arm.

          -  Parental written informed consent for participation in the study obtained on admission
             into the hospital or prior to delivery.

        Exclusion Criteria:

          -  Evidence of severe birth asphyxia, that is an APGAR score below 3 at 5 minutes of age.

          -  Need for endotracheal intubation for cardiopulmonary resuscitation or insufficient
             respiratory drive.

          -  Known genetic or chromosomal disorders.

          -  Delivered to mothers with ruptured membranes of more than 3 weeks duration.

          -  Potentially life-threatening conditions unrelated to immaturity.

          -  Participation in another clinical trial of any placebo, drug, biological, or device
             conducted under the provisions of a protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Weeks</minimum_age>
    <maximum_age>28 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Fabbri</last_name>
    <role>Study Director</role>
    <affiliation>Medical Department; Chiesi Farmaceutici S.p.A (Italy)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Faculty Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital De La Conception</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternidade Alfredo da Costa</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital De Cruces</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>France</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>https://www.clinicaltrialsregister.eu/ctr-search/search?query=2006-004105-25</url>
    <description>Study Record on EU Clinical Trials Register including results</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2007</study_first_submitted>
  <study_first_submitted_qc>July 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2007</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surfactant</keyword>
  <keyword>RDS</keyword>
  <keyword>nCPAP</keyword>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>Premature Infants</keyword>
  <keyword>Neonatal Respiratory Distress Syndrome (nRDS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poractant alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

